发明名称 |
Anti-IL-12 Antibodies and Compositions |
摘要 |
Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as psoriasis. |
申请公布号 |
US2017029496(A1) |
申请公布日期 |
2017.02.02 |
申请号 |
US201615198678 |
申请日期 |
2016.06.30 |
申请人 |
Giles-Komar Jill;Knight David M.;Peritt David;Scallon Bernard;Shealy David |
发明人 |
Giles-Komar Jill;Knight David M.;Peritt David;Scallon Bernard;Shealy David |
分类号 |
C07K16/24 |
主分类号 |
C07K16/24 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pen-injector containing a liquid pharmaceutical formulation comprising an effective amount of an isolated anti-IL-12 antibody having a heavy chain variable region and a light chain variable region, said heavy chain variable region comprising:
a heavy chain complementarity determining region 1 (CDR1) comprising the amino acid sequence of SEQ ID NO:1, a heavy chain complementarity determining region 2 (CDR2) comprising the amino acid sequence of SEQ ID NO:2, a heavy chain complementarity determining region 3 (CDR3) comprising the amino acid sequence of SEQ ID NO:3, said light chain variable region comprising: a light chain complementarity determining region 1 (CDR1) comprising the amino acid sequence of SEQ ID NO:4, a light chain complementarity determining region 2 (CDR2) comprising the amino acid sequence of SEQ ID NO:5, and a light chain complementarity determining region 3 (CDR3) comprising the amino acid sequence of SEQ ID NO:6. |
地址 |
Downingtown PA US |